Fig. 2From: Hexavalent vaccines in preterm infants: an update by Italian Society of Pediatric Allergy and Immunology jointly with the Italian Society of NeonatologyInfanrix Hexa®, Hexyon® e Vaxelis®. Summary of product characteristics as reported by EMA (European Medicine Agency). Paragraph concerning safety in preterm infants, including those born with ≤28 weeks of gestational age and/or recent history of respiratory distressBack to article page